These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist, not a pure GLP-1 agonist
Is retatrutide a GLP-1
Exendin-4 (exenatide) has been shown to be effective in a mouse model of ALD, ameliorating hepatic steatosis and improving metabolic markers such as insulin resistance and lipid levels
For weight loss, Ozempic has proven to be highly effective
By monitoring Loss of Exclusivity (LOE) forecasts and performing white space analysis, facilities can identify therapeutic areas with high demand but low patent density, or identify when specific formulation patents expire, allowing for the legal production of non-infringing compounds